Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Simone Ernst"'
Autor:
Simone Ernst
Publikováno v:
Zeitschrift für das Privatrecht der Europäischen Union. 16:133-140
Autor:
Julia Heinzelbecker, Kerstin Junker, Rainer M. Bohle, J. Heinzelmann, Georg Weber, Simone Ernst, Michael Stöckle
BACKGROUND Seminomatous germ cell tumours (SGCT) are the most frequent malignancy in young men. Reliable prognostic biomarkers for the prediction of metastasis at diagnosis and the risk of relapse in clinical stage I (CSI) are lacking. Adjuvant thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb2df0b20907101d7af3db19a8df774
Autor:
Boris Schlenker, Isabella Syring, Jonas Hermann, Maximilian P Brandt, Johannes Salem, Pia Paffenholz, Tim Nestler, Simone Ernst, Friedemann Zengerling, Christian Ruf, Maria Schubert
Publikováno v:
Der Urologe. 56:1044-1046
Autor:
Carsten-Henning Ohlmann, Matthias Saar, Stefan Ueberdiek, Julia Heinzelbecker, Michael Stoeckle, Horst Brenneis, Simone Ernst, Reinhard Kubale
Publikováno v:
Urologia Internationalis. 101:114-116
The incidence of segmental testicular infarction (STI) is very low. Such a disorder most often affects young men. The most common symptom is sudden testicular pain. We report 6 cases of men diagnosed with STI. Clinical examination, blood test, urine
Autor:
Michael Stöckle, Sebastian Hölters, Julia Heinzelbecker, Georg Weber, Simone Ernst, Rainer M. Bohle, Kerstin Junker, Joana Heinzelmann
Publikováno v:
Journal of Urology. 199
Autor:
Jan Lehmann, Maximilian Cohausz, Carsten-Henning Ohlmann, Julia Heinzelbecker, Michael Stöckle, Simone Ernst, Karla Kaßmann
Publikováno v:
Journal of Urology. 199
Autor:
Anne Weiland, J. Heinzelmann, Darja Schendel, Kerstin Junker, Gerhard Unteregger, Simone Ernst, Michael Stoeckle
Publikováno v:
Cancer Research. 74:1712-1712
Introduction: Treatment of advanced renal cell carcinoma (RCC) by tyrosine kinase inhibitors like Sunitinib (SUN) is hampered by the appearance of drug resistance. Sequence therapy using different TKIs as well as inhibitors attacking the mTOR pathway